Clinical Trial offers Hope for Treatment of Hypo-Hypo Infertility (Absent Periods)
This Study is Closed to Enrollment
Suffering from infertility can be an extremely emotional and difficult experience for individuals–and for couples. Without the ability to create a family, many feel less than whole. And solutions don’t always come easily.
Infertility is also a very common ailment. According to the Centers for Disease Control, approximately 1 in 8 couples suffer from some form of infertility, which may be related to one or both members of the relationship. The causes of infertility are varied, and some causes are much less common than others.
In one form of infertility, referred to as Hypo-Hypo or hypogonadotropic hypogonadism, a woman’s menstrual cycle is inhibited (absent periods) because the hypothalamus of the brain fails to stimulate the ovaries. Without the hormone changes within a typical menstrual cycle, the woman is unable to develop or release mature eggs for fertilization.
In one rare subset of hypo-hypo patients, Kallmann’s syndrome, a woman is unable to have a spontaneous menses at any point in their life. Kallman’s Syndrome is a genetic condition and can be extremely difficult to treat. As a result, many fertility patients with this rare condition have tried conventional treatments without much success.
Clinical Trial for Infertility from Kallman’s Syndrome
Luckily, medical professionals have been working to develop an effective treatment for Kallman’s Syndrome, and there are some novel approaches currently in the clinical trial phase. If you live with Kallman’s Syndrome, and you have dreams of creating a family, contact Physicians Research Group to find out how you can participate in a clinical trial. There is hope for you–and your participation in a clinical trial can bring hope to others in the same situation.